Is CHUC The Next MNST Monster Beverage?

Monster Beverage MNST was to the caffeine energy drink market as Charlie’s Holdings CHUC is to flavored nicotine.

Both launched category killer products as a completely unknown penny stock.

When people talk about the best stocks of the last 20 years, they usually guess Apple, Amazon, Microsoft, and maybe Google.

Almost nobody guesses the real answer.

It was Monster Beverage, ticker MNST.

Monster Beverage Started As Hansen Natural, A Penny Stock

Before stadiums, sponsorships, and billions in revenue, Monster Beverage started as a tiny company called Hansen Natural. It traded under ten cents a share. It was a penny stock. Institutions could not touch it. Analysts ignored it.

That was right when Monster Energy drink first launched.

If someone had invested just $1,000 into Hansen Natural when Monster Energy drink launched, that investment would be worth well over $1 million today.

That is a better return than Apple.

So what really happened?

It was not magic. It was a product pattern.

And that same pattern is quietly forming again with Charlie’s Holdings (CHUC) and its flavored vape, SBX.

Here’s how CHUC is stealing MNST’s playbook.

Red Bull Created The Caffeine Energy Drink Category but Monster Beverage Perfected It

Red Bull created the energy drink category.

Before Red Bull, people drank coffee and soda for a caffeine boost. Red Bull introduced a new way to consume energy.

But early Red Bull had problems.

It tasted harsh.
It came in tiny cans.

It was expensive.

People drank it because it was new, not because it was enjoyable.

In 2002, Hansen Natural launched Monster Energy with a different idea.

Make it taste more like soda.
Make the can bigger.
Make it feel like real value.

And consumers did what they always do when a better product comes along: they switched.

At the time, Hansen stock stayed under $0.10 for months. No institutions. No research coverage. No hype. But something important was happening underneath.

Sales were compounding quietly.

Monster did not win by shouting louder. It won by building something people preferred.

Years later, Coca Cola invested $2.15 billion for 16 percent of Monster.

Big money followed demand.

JUUL Started The Nicotine Vape Category and SBX Is Improving It

Now look at nicotine.

JUUL pioneered modern vaping, much like Red Bull pioneered energy drinks. It introduced a new category for how people consume nicotine, smoke free nicotine.

But JUUL today has the same early-category problems Red Bull had.

Mostly tobacco and menthol flavors.
Only a few hundred puffs per device.
Growing regulatory pressure.

Consumers want flavor. They want longevity. They want a better experience.

That is where SBX from CHUC comes in.

SBX focuses on the user, not just the concept.

In taste tests, 94 percent of users choose SBX over JUUL.

SBX comes in 14 flavors, not just tobacco and menthol.

It delivers up to 25,000 puffs, not a few hundred.

It is legal in almost all 50 states.

Just like Monster improved Red Bull, SBX improves JUUL.

Instead of caffeine, it is nicotine.

Revenue Comes Before Recognition

When Monster launched, institutions could not buy Hansen Natural. The stock was too small. Brokers restricted it. Analysts ignored it.

Yet revenue grew anyway.

CHUC sits in a similar zone today.

No meaningful research coverage.
Institutions largely locked out.
Some brokerages restrict trading.

In fact, SBX is on pace to generate more first-year revenue than Monster did in its first year, even though SBX is only in a handful of states and has almost no marketing budget.

That matters.

Products that sell without marketing usually sell much faster when distribution expands.

Marketing adds gasoline, but the engine is the product.

Why Energy Drinks And Nicotine Scale Alike

Energy drinks and nicotine share the same business physics.

• Repeat consumption
• Taste driven adoption
• Fast brand loyalty
• Social spread
• Massive markets

The global energy drink market is around $45 billion.
The global e-cigarette market is around $35 billion.

Monster did not invent the energy drink. It replaced the first mover with a better product.

SBX is trying to do the same in vaping.

Big Players Follow Proven Demand

Big companies do not buy IDEAS, they BUY PROOF.

Coca Cola bought into Monster for $2.15B

Altria bought into JUUL for $12.8B

They waited intil consumers had already voted with their wallets.

Right now, SBX is still in that proof phase.

• Users prefer it
• Revenue is rising
• Insitutional attention has not arrived…YET

That gap between adoption and recognition is where outsized returns usually live.

CHUC Looks Like MNST When It Was A Penny Stock

The best investments usually look univestable at first.

Before Monster was MNST, it was Hansen Natural.

Before analysts, there were taste tests.

Before institutions, there was revenue.

Today, SBX is showing a similar consumer pattern inside CHUC.

• No coverage
• Limited access
• But real adoption

History never repeats perfectly, but it often rhymes.

When CHUC rolls out SBX with built in continuous age gating, disrupting the category becomes eliminating the competition.

Other Articles About Charlie’s Holdings OTCQB:CHUC

• OTCQB:CHUC Best Nicotine Vape Stock
• Best Profitable Penny Stock for 2026
• Big Tobacco Quietly Acquires CHUC PMTAs
• OTCQB:CHUC Investor Deck
• CHUC’s Latest Shareholder Letter
• Charlie’s Holdings OTCQB: CHUC Oct 2025 Interview
• CHUC Launches SBX Product Delivers 336% Q3 Revenue Growth
• BEST Profitable Penny Stock With Insider Buying
• IKE Tech and CHUC Partner for FIRST US Age Gating System
• Charlies Holdings Investor Summary 2026

Safe Harbor Statement: This interview contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company’s overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company’s ability to successfully increase sales and enter new markets; whether the Company’s PMTA’s for its nicotine-containing products will be authorized by the FDA, and the FDA’s decisions with respect to the Company’s future PMTA’s for nicotine products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, and products containing nicotine substitutes; litigation risks from the use of the Company’s products; risks of government regulations; the impact of competitive products; and the Company’s ability to maintain and enhance its brands, as well as other risk factors included in the Company’s most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this interview and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this interview as a result of new information, future events or changes in its expectations.

Artificial Intelligence Stock Reading

• The Best Artificial Intelligence Penny Stock VERSES AI
• Artificial Intelligence Stock with BIGGEST Potential
• What is BETTER than ChatGPT Generative Artificial Intelligence
• Generative Artificial Intelligence Regulation Solution
• How To Govern and Regulate Artificial Intelligence
• The BEST C3 AI Stock Alternative
• Next Generation Intelligence Patent Application
• The ONLY Adaptive Artificial Intelligence Stock
• Artificial Intelligence Stocks
• VERSES VRSSF 2023 Year End Summary
• The Story of VERSES AI VRSSF
• How VERSES AI Solves the Generative AI Problem